Description:TECHNICAL FIELD
[0001] The present disclosure relates to the field of an insulin delivery device. More particularly, the present disclosure relates to an insulin delivery device with smart communication capabilities, realizing of automated insulin delivery for severe diabetic patients making easy, affordable and reliable.

BACKGROUND
[0002] Background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention or that any publication specifically or implicitly referenced is prior art.
[0003] Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient production or ineffective use of insulin. Insulin, a hormone produced by the pancreas, plays a crucial role in regulating blood sugar levels. There are two primary types of diabetes: type 1, an autoimmune disease typically diagnosed in childhood, and type 2, more common in adults and often associated with factors like obesity and a sedentary lifestyle.
[0004] Complications associated with diabetes include cardiovascular disease, kidney failure, nerve damage, and vision impairment, making it a significant global health concern. However, effective management strategies can enable individuals with diabetes to lead healthy and productive lives.
[0005] Traditional methods of insulin administration involve injections using syringes or insulin pens, with doses measured and injected into fatty tissue beneath the skin. Multiple injections may be required daily, depending on insulin type and individual requirements. Insulin pumps, on the other hand, deliver a continuous supply of insulin through a small tube inserted under the skin. These pumps can be programmed to provide precise insulin doses throughout the day and night.
[0006] While these traditional insulin delivery methods have proven effective over the years, they do have drawbacks. Injections can be uncomfortable and lead to bruising or scarring over time. Adhering to a regimen of multiple daily injections can also be challenging. Insulin pumps, although effective, can be costly and demand regular maintenance. Both methods necessitate diligent monitoring of blood sugar levels to ensure appropriate insulin dosage.
[0007] In recent years, advancements in technology and medical devices have aimed to address these limitations and enhance diabetes management. These innovations include alternative insulin delivery systems, such as insulin pens with finer needles for reduced discomfort and greater convenience, and continuous glucose monitoring systems that provide real-time blood sugar readings to guide insulin dosing decisions.
[0008] By continually improving insulin delivery methods and embracing technological advancements, healthcare professionals strive to optimize diabetes management and enhance the quality of life for individuals living with this condition.
[0009] Conventional approaches, such as injections of insulin pumps, require manual adjustments by the patient to regulate blood sugar levels. This can be time-consuming, inconvenient, and prone to dosing errors. Furthermore, traditional methods lack real-time responsiveness to changes in blood sugar levels.
[0010] There is, therefore, a need to provide an innovative insulin delivery device with smart communication capabilities, offers optimized and autonomous bolus doses of insulin based on a doctor’s pre-defined profile, and serves as an alternative to multiple daily insulin injections and is particularly beneficial for individuals struggling to achieve optimal blood sugar control through injections.

OBJECTS OF THE PRESENT DISCLOSURE
[0011] Some of the objects of the present disclosure, which at least one embodiment herein satisfy are listed herein below.
[0012] It is an object of the present disclosure is to provide an integrated device that effectively manages diabetes by combining glucose monitoring and insulin delivery in a seamless and coordinated manner.
[0013] Another object of the present disclosure is to enable real-time monitoring of blood glucose levels through a connected glucometer sensor, allowing for timely adjustments in insulin delivery based on the user’s glucose data.
[0014] Another object of the present disclosure is to ensure precise and controlled insulin delivery, allowing for personalized dosing adjustments based on the user's specific needs and glucose level variations.
[0015] Yet another object of the present disclosure is to establish seamless connectivity between the device and external components, such as a smartphone app, ensuring efficient data transfer and communication for optimized diabetes management.

SUMMARY
[0016] The present disclosure relates to the field of an insulin delivery system. More particularly, the present disclosure relates to an innovative insulin delivery system with smart communication capabilities, realizing the delivering of automated insulin delivery for severe diabetic patients making it easy, affordable and reliable.
[0017] Another aspect of the present disclosure is an insulin delivery device of delivering insulin to a user body with diabetes, including an outer covering box may be configured to involve a first brushless DC (BLDC) motor, and a second brushless DC (BLDC) motor mount on a central link and placed inside the outer covering box.
[0018] Furthermore, the first BLDC motor, and the second BLDC motor can facilitate insulin delivery in the user’ body, where the first BLDC motor includes a first motor shaft, and attached to a one side of first major link of the first BLDC motor, where the one side of first major link further connected to a one side of first minor link of the first BLDC motor.
[0019] Moreover, the second BLDC motor includes a second motor shaft, and attached to a one side of second major link of the second BLDC motor, where the one side of second major link further connected to one side of a second minor link of the second BLDC motor.
[0020] In an aspect, the first and second motor shaft of the first and second BLDC motor respectively connected to the first and second major links, and minor links to control dosage of the insulin in the user’ body.
[0021] Moreover, a vertical shaft installed on a piston block, where the piston block configured to connect with a second side of the first and second minor link of the first and second BLDC motors respectively to synchronize movement of the insulin delivery. A piston block connected to a cylinder with a plurality of apertures and a piston, where the plurality of apertures correspondingly connected to a first and second pipe.
[0022] In an aspect, a first and second valve configured to attach to the first and second pipes to facilitate controlled insulin delivery in the user’ body, and an infrared (IR) sensor attached to the central link to track movement of the piston, and correspondingly provide a real-time feedback of the insulin delivery device. The infrared (IR) sensor may be configured to ensure whether the motor is working properly. In an event that there may be multiple fault concerning the motor operation, and displacement of the piston, including but not limited to, the controller can come to know and the system may generate an error. Therefore, the insulin delivery device sends a command to stop the haywire operation of the first and second BLDC motors and further inject incorrect amounts of insulin.
[0023] In an aspect, a first Bluetooth device embedded with the insulin delivery device to communicate with a user interface.
[0024] Another aspect of the present disclosure an insulin patch device for measuring sugar level in a user’ body and deliver insulin into the user’ body using an insulin delivery device including a housing of the insulin patch device positioned below an insulin delivery device, and configured to attach with a locking mechanism, includes a plurality of syringe, involves a first syringe may be attached to a first pipe of the insulin delivery device to transfer insulin from a cylinder to the first pipe of the insulin delivery device, where the insulin configured to flow into a patch pipe and be injected into the user’s body using the first syringe; a second syringe attached to a glucometer sensor within the housing to monitor the user’s body blood glucose level; a needle attached to the second pipe that leads to a reservoir, where the second pipe configured to insert into the reservoir; and a second Bluetooth device embedded within the housing facilitates transmission of a blood glucose data of the user to a computing device.
[0025] In an aspect, the insulin delivery device configured to receive glucose level data from the insulin patch device, analyse the received glucose level data, and correspondingly adjust insulin delivery by the insulin delivery device based on the received glucose level data.
[0026] In an aspect, one or more power supply unit is positioned with the first Bluetooth device inside the outer covering box within the insulin delivery device.
[0027] In an aspect, a control unit to provide personalized recommendations for insulin dosage based on the user’s glucose level data. The control unit is further configured to provide notifications to any or a combination of, the user, and a healthcare provider when the insulin levels in the cylinder fall below predetermined thresholds.
[0028] In an aspect, a motor driver with processor attached inside the outer covering box with the first and second BLDC motor, and configured to drive rotation of the first and second motor shaft. The insulin patch device may be configured to include a cap that rests on a cap holder located on a side wall of the insulin patch device when the insulin delivery device is attached.
[0029] Various objects, features, aspects, and advantages of the inventive subject matter will become more apparent from the following detailed description of preferred embodiments, along with the accompanying drawing figures in which like numerals represent like components.

BRIEF DESCRIPTION OF DRAWINGS
[0030] The accompanying drawings are included to provide a further understanding of the present disclosure and are incorporated in, and constitute a part of this specification. The drawings illustrate exemplary embodiments of the present disclosure, and together with the description, serve to explain the principles of the present disclosure.
[0031] In the figures, similar components, and/or features may have the same reference label. Further, various components of the same type may be distinguished by following the reference label with a second label that distinguishes among the similar components. If only the first reference label is used in the specification, the description is applicable to any one of the similar components having the same first reference label irrespective of the second reference label.
[0032] FIG. 1A illustrates exemplary functional components top view of an insulin delivery device with an outer covering box, in accordance with an embodiment of the present disclosure.
[0033] FIG. 1B illustrates the exemplary functional components of an insulin delivery device with a plurality of mechanical components, in accordance with an embodiment of the present disclosure.
[0034] FIG. 1C illustrates another exemplary functional components of an insulin delivery device focusing on piston mechanism, in accordance with an embodiment of the present disclosure.
[0035] FIG. 2A illustrates the exemplary functional components of an isometric view for an insulin patch device, in accordance with an embodiment of the present disclosure.
[0036] FIG. 2B illustrates the exemplary functional components of a side view for an insulin patch device, in accordance with an embodiment of the present disclosure.
[0037] FIG. 2C illustrates the exemplary functional components of a detailed CAD model for an insulin patch device, in accordance with an embodiment of the present disclosure.
[0038] FIG. 3 illustrates an exemplary functional component of a complete assembly of an insulin delivery device installed above on an insulin patch device, in accordance with an embodiment of the present disclosure.
[0039] FIG. 4 illustrates an exemplary device for battery assembly of an insulin delivery device installed above on an insulin patch device, in accordance with an embodiment of the present disclosure.
[0040] FIG. 5 illustrates an exemplary functional establishment seamless connectivity between the insulin delivery and insulin patch device and a user interface, for example a smartphone app, ensuring efficient data transfer, in accordance with an embodiment of the present disclosure.
[0041] FIG. 6 illustrates an exemplary flowchart of seamless connectivity between the insulin delivery, insulin patch device and user interface, for example a smartphone app, ensuring efficient data transfer, in accordance with an embodiment of the present disclosure.

DETAILED DESCRIPTION
[0042] The following is a detailed description of embodiments of the disclosure depicted in the accompanying drawings. The embodiments are in such detail as to clearly communicate the disclosure. However, the amount of detail offered is not intended to limit the anticipated variations of embodiments. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit, and scope of the present disclosure as defined by the appended claims.
[0043] In the following description, numerous specific details are set forth in order to provide a thorough understanding of the embodiments of the present invention. It will be apparent to one skilled in the art that embodiments of the present invention may be practiced without some of these specific details. Embodiments of this disclosure relate to an insulin delivery device. More particularly, the present disclosure relates to an innovative insulin delivery system with smart communication capabilities, realizing the delivering of automated insulin delivery for severe diabetic patients making it easy, affordable and reliable.
[0044] If the specification states a component or feature “may”, “can”, “could”, or “might” be included or have a characteristic, that particular component or feature is not required to be included or have the characteristic.
[0045] As used in the description herein and throughout the claims that follow, the meaning of “a,” “an,” and “the” includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein, the meaning of “in” includes “in” and “on” unless the context clearly dictates otherwise.
[0046] Embodiment of the present disclosure is an insulin delivery device of delivering insulin to a user’ body with diabetes, including an outer covering box may be configured to involve a first brushless DC (BLDC) motor, and a second brushless DC (BLDC) motor mount on a central link and placed inside the outer covering box.
[0047] Furthermore, the first BLDC motor, and the second BLDC motor can facilitate insulin delivery in the user’ body, where the first BLDC motor includes a first motor shaft, and attached to a one side of first major link of the first BLDC motor, where the one side of first major link further connected to a one side of first minor link of the first BLDC motor.
[0048] In an embodiment, the second BLDC motor includes a second motor shaft, and attached to a one side of second major link of the second BLDC motor, where the one side of second major link further connected to one side of a second minor link of the second BLDC motor. Furthermore, the first and second motor shaft of the first and second BLDC motor respectively connected to the first and second major links, and minor links to control dosage of the insulin in the user’ body.
[0049] Moreover, a vertical shaft installed on a piston block, where the piston block configured to connect with a second side of the first and second minor link of the first and second BLDC motors respectively to synchronize movement of the insulin delivery. A piston block connected to a cylinder with a plurality of apertures and a piston, where the plurality of apertures correspondingly connected to a first and second pipe.
[0050] In an embodiment, a first and second valve configured to attach to the first and second pipes to facilitate controlled insulin delivery in the user’ body, and an infrared (IR) sensor attached to the central link to track movement of the piston, and correspondingly provide a real-time feedback of the insulin delivery device.
[0051] Another embodiment of the present disclosure an insulin patch device for measuring sugar level in a user’ body and deliver insulin into the user’ body using an insulin delivery device including a housing of the insulin patch device positioned below an insulin delivery device, and configured to attach with a locking mechanism, includes a plurality of syringe, involves a first syringe may be attached to a first pipe of the insulin delivery device to transfer insulin from a cylinder to the first pipe of the insulin delivery device, where the insulin configured to flow into a patch pipe and be injected into the user’s body using the first syringe; a second syringe attached to a glucometer sensor within the housing to monitor the user’s body blood glucose level; a needle attached to the second pipe that leads to a reservoir, where the second pipe configured to insert into the reservoir; and a second Bluetooth device embedded within the housing facilitates transmission of a blood glucose data of the user to a computing device.
[0052] FIG. 1A illustrates exemplary functional components top view of an insulin delivery device with an outer covering box, in accordance with an embodiment of the present disclosure.
[0053] Referring to FIG. 1A illustrate an innovative insulin delivery device 100 (interchangeably referred to as a delivery device 100, hereinafter) with smart communication capabilities may be configured to offer optimized and autonomous bolus doses of insulin based on a doctor’s pre-defined profile for medical purposes. The device 100 may be divided into two parts; one is electronics parts and other one is mechanical parts, including any or a combination of, but not limited to, motors, batteries, cables, electronics valves, linkages, a plurality of syringes and sensors can need to build the entire delivery device 100. The construction can begin with the creation of an outer covering box 102 that encapsulates all the internal components. The outer covering box 102 is meticulously crafted in accordance with the specifications outlined in the Computer-Aided Design (CAD) model, ensuring precision and alignment with the digital representation of the delivery device 100 structure. A critical aspect of the construction can lie in the careful selection of materials endowed with specific properties. These materials are chosen based on their capacity for waterproofing, shielding the device against moisture or liquid ingress; corrosion resistance, safeguarding against deterioration over time; and durability, ensuring resilience against environmental factors and physical stress. Moreover, the outer covering box 102 may incorporate a sophisticated locking mechanism, serving a dual purpose. On one hand, it fortifies the security of the delivery device 100 by preventing unauthorized access, ensuring the integrity of its internal components. On the other hand, the outer covering box 102 may incorporate as a barrier, prohibiting the entry or exit of any other substance, further enhancing the protective features of the outer covering. A first Bluetooth device 134 may be configured to implant with the outer covering box 102 to communicate with a user interface 502.
[0054] FIG. 1B illustrates the exemplary functional components of an insulin delivery device with a plurality of mechanical components, in accordance with an embodiment of the present disclosure.
[0055] Referring to FIG. 1B illustrate a plurality of mechanical components any or a combination of, a first brushless DC (BLDC) motor 104-1, and a second brushless DC (BLDC) motor 104-2 may be configured to mount on a central link 106 that has been placed inside the outer covering box 102 as shown in FIG. 1B. Moreover, a first motor shaft 108-1, and second motor shaft 108-2 can attach to one side of the first major link 110-1, and the second major link 110-2 respectively. The one side of first and second major link 110 further connected to a one side of first and second minor link 112 of the first and second BLDC motor. Furthermore, the first and second motor shaft 108 of the first and second BLDC motor 104 respectively connected to the first and second major links 110, and minor links 112 to control dosage of the insulin in the body of the user.
[0056] FIG. 1C illustrates another exemplary functional components of an insulin delivery device focusing on piston mechanism, in accordance with an embodiment of the present disclosure.
[0057] In an exemplary embodiment, a vertical shaft 114 can install on a piston block 116, and further connected to a second side of the first and second minor link 112. The piston block 116 may be connected to a cylinder 118 with a plurality of apertures and the piston 120, and at the plurality of apertures, a first pipe 122-1 and a second pipe 122-2 with a first valve 124-1 and a second valve 124-2 may be configured to attach to facilitate controlled insulin delivery in the body of the user as shown in FIG. 1C. Furthermore, a needle 136 is attached to the second pipe 122-2 that leads to a reservoir 128. The second pipe 122-2 may be inserted into the reservoir 128, and a piston 120 may move down to draw insulin from the reservoir 128 with the assistance of the needle 136.
[0058] FIG. 2A illustrates the exemplary functional components of an isometric view for an insulin patch device, FIG. 2B illustrates a side view for an insulin patch device, and FIG. 2C illustrates a detailed CAD model for an insulin patch device, in accordance with an embodiment of the present disclosure.
[0059] In an exemplary embodiment, a housing 202 of a insulin patch device 200 positioned below an insulin delivery device 100 (interchangeably referred to as a patch device or a sticky patch device 200, hereinafter), and configured to attach with a locking mechanism, includes a first syringe 210-1 may be attached to the first pipe 122-1 to transfer insulin from the cylinder 118 to the first pipe 122-1. Subsequently, the insulin can flow into a patch pipe 214 and be injected into the user’s body using the first syringe 210-1, a second syringe 210-2 may be attached to a glucometer sensor 218 to continuously monitor the user’s body blood glucose level and share the data using a second Bluetooth device 220 that is included in the patch device 200 to the user interface 502. At the central link 106, a single IR sensor 126 is set up to track the movement of the piston 120. A first Bluetooth device 134 and a motor driver with processor 130 (interchangeably referred to as a processor 130, hereinafter) may be installed accordingly in the FIGs. 1A - 1C and the FIGs. 2A - 2C the plurality of the mechanical parts have been attached, and one or more power supply unit 400 may be placed above the first Bluetooth device 134. Furthermore, the one or more power supply unit 400 may be positioned on two resting support 132 one is a first resting support 132-1 and a second resting support 132-2. A third supporting rest 132-3 may be positioned to hold the reservoir 128.
[0060] In an exemplary embodiment, the patch device 200 may be configured to include a coincell battery 216, known as a coin cell or button cell, is a small, disc-shaped, and typically cylindrical battery designed for use in multiple electronic devices, particularly those with low power requirements. Further, the coincell battery 216 positioned at base of the patch device 200, and besides the patch pipe 214 embedded within the housing 202 facilities for low power requirements.
[0061] Furthermore, a second Bluetooth device 220 embedded within the housing 202 facilitates transmission of a blood glucose data of the user to a computing device, the first and second pipes 122, the first and second syringe 210, the glucometer sensor 218 to test glucose levels may need to assemble the patch device 200. The first and second syringes 210 may be affixed to the bottom of the patch device 200. The patch pipe 214 is attached to the first syringe 210-1, while the glucometer sensor 218 is connected to the second syringe 210-2. At the side wall 204 of the patch device 200, a cap 208 and cap holder 206 are likewise constructed. The first Bluetooth device 134, the one or more power supply unit 400, and the one or more mechanical parts may assemble in accordance with as shown in FIGs. 1A - 1C, FIGs. 2A - 2 C, and FIG. 4.
[0062] In an exemplary embodiment, a construction of an application (interchangeably referred to as a user interface 502, hereinafter) may be designed in such a way that the delivery device 100, and the patch device 200 may be configured to allow a doctor to input their insulin dosing information and monitor their glucose levels in real time. Furthermore, the user interface 502 may be integrated with the delivery device 100, and the patch device 200. The integration may involve developing communication protocols and Application Programming Interface (APIs) to allow the user interface 502 to communicate with the delivery device 100, and the patch device 200. The user interface 502 may be able to receive data from the delivery device 100, such as the current insulin dosage and remaining insulin levels, and send commands to adjust the dosage in accordingly with help of the user interface 502.
[0063] In an exemplary embodiment, the user interface 502 can be configured to connect with the patch device 200 via the second Bluetooth device 220. The user interface 502 allows for easy adjustment of insulin doses and provides alerts for potential high or low glucose levels. The body glucose is being real-time monitored by the patch device 200. If there is a sudden change in the measured insulin, the patch device 200 directly communicates with the mobile application, generating notifications via Bluetooth communication. Further, the patch device 200 may be sending the signals to the delivery device 100. Upon reception of such signals from the patch device 200, the delivery device 100 generates alarming sounds and notifies the user by blinking of the red LED.
[0064] Furthermore, the user interface 502 may be able to store data any or a combination of, but not limited to, an insulin dosing, glucose levels, and one or more relevant information. This data can be analysed to identify trends and patterns in the user’s glucose levels and insulin needs which can be analysed by the doctors. This information from the doctor can then be used to adjust dosing and optimize insulin delivery through the user interface 502.
[0065] FIG. 3 illustrates an exemplary functional component of a complete assembly 300 of an insulin delivery device installed above on an insulin patch device, in accordance with an embodiment of the present disclosure.
[0066] FIG. 5 illustrates an exemplary functional establishment, and seamless connectivity between the insulin delivery device and insulin patch device and a user interface, for example a smartphone app, ensuring efficient data transfer, in accordance with an embodiment of the present disclosure.
[0067] In an exemplary embodiment, the complete assembly 300 involves three components that can make up to provide artificial insulin delivery in the user body given as; the user interface 502, the delivery device 100, and the Patch device 200. The patch device 200 is a special tool that may help to measure every user’s sugar level and deliver insulin into the body. The patch device 200 has adhered to the body of the user, and the first and second syringe 210 may be inserted, and a delivery device 100 may be positioned above the patch device 200 using one or more clips 222 as shown in FIG. 3. The patch device 200 possesses the first and second syringes 210, one or more power supply 400 and other electronic devices. The first syringe 210-1 can inject the necessary and prescribed insulin into the body of the user and the second syringe 210-2 can continuously check the body’s blood glucose level at any time with the help of the glucometer sensor 218 that is connected to the second syringe 210-2 and share the data using the second Bluetooth module 220 that is included in the patch device 200 to the user interface 502. This makes it simple to track blood sugar levels throughout the day and to get data on how things change over time.
[0068] In an exemplary embodiment, the patch device 200 features the cap 208 which rests on the cap holder 206 on the side wall 204 of the patch device 200 when the delivery device 100 may be attached. The cap 208 is to close the patch pipe 214 mouth when the delivery device 100 is not connected with the patch device 200. So dust or foreign particles cannot go inside the patch pipe 214. The user interface 502 can determine how much insulin needs to be injected into the user’s body based on their blood glucose level. Once the signal is transmitted from the user interface 502 to the second Bluetooth unit 220 located on the patch device 200, where the patch device 200 may be configured to measure the body glucose level and send the measurement to the delivery device 100 using the first and second Bluetooth communication between 220 and 134. Then the measured signal goes to the processor 134, and the processor 134 triggers the motor drivers 134 to initiate the controlled movements of the motors 104 which is subsequently relayed to the processor 130. The processor 130, in turn, may be initiating the rotation of the first and second motor shafts 108. The first and second BLDC motors 104 may be used throughout, and both are connected to the processor 130 so that the movement of the motor shaft 108 can be effortlessly handled.
[0069] In an exemplary embodiment, as the signal comes, the first and second motor shafts 108 can rotate clockwise and anti-clockwise directions simultaneously which can rotate the first and second major links 110 which are connected with the first and second motor shafts 108 may also rotate along with it. Moreover, the first and second minor links 112 which may be connected at the second end of the major link 110 also move vertically up and down. Furthermore, the first and second major link 110 and the first and second minor links 112 relates to the vertical shaft 114 which is mounted on the piston block 116. When the first and second minor links 112 are adjustable to move both upward and downward, the entire device, including the piston block 116 and piston head 120, undergoes motion.
[0070] In an exemplary embodiment, First, the first valve 124-1 (interchangeably referred to as a outlet valve 124-1, hereinafter) must be closed, therefore the second valve 124-2 (interchangeably referred to as a inlet valve 124-2, hereinafter) must be opened, then slowly the first and second motors 104 revolve clockwise and anticlockwise respectively simultaneously according to the piston 120 to go down and suck the insulin from the reservoir 128 with the help of the Needle 136.
[0071] In an exemplary embodiment, after the cylinder 118 has received enough insulin through the second pipe 122-2 using the needle 136, the outlet valve 124-1 is opened, and the inlet valve 124-2 is closed, and the process is then repeated in the opposite direction. As a result, the piston 120 can push the insulin which is present inside the cylinder 118. Thus, the insulin configured to transfer from the cylinder 118 to the first pipe 122-1 and further enter the patch pipe 214, and then be injected into the user’s body using the first syringe 210-1. The IR sensor 126 is positioned behind the piston block 116 to measure the distance between them to make sure the delivery device 100 is functioning properly. If the piston 120 distances may not change after receiving the signal from the user interface 502, this can alert the user to a device malfunction, allowing them to take the necessary steps.
[0072] In an exemplary embodiment, a registration of the users may be an essential part of developing the smart insulin delivery device 100 and the user interface 502. The registration process may be designed to be simple and easy to use while ensuring the security of the user data. Here are one or more steps that could be followed for the user registration in the user interface 502.
[0073] FIG. 6 illustrates an exemplary flowchart of seamless connectivity between the insulin delivery, insulin patch device and user interface, for example a smartphone app, ensuring efficient data transfer, in accordance with an embodiment of the present disclosure.
[0074] Referring to FIG. 6, a method 600 can be configured to one or more steps that could be followed for the user registration in the user interface 502 and control of glucose monitoring and insulation delivery, embodiments of the present disclosure include various steps, which will be described below. The steps may be performed by hardware components or may be embodied in machine-executable instructions, which may be used to cause a general-purpose or special-purpose processor programmed with the instructions to perform the steps. Alternatively, the steps may be performed by a combination of hardware, software, firmware, and/or by human operators.
[0075] At step 602, the method 600 involves process of accessing a user account or personal profile or application through the use of login credentials. When the users engage in a profile login, they typically enter a combination of a username or email address and a password to authenticate their identity and gain access to their individual account.
[0076] At step 604, the decision unit verifies whether a user account or profile is new or has been previously established. If the determination is yes then the step 604 proceeds from step 604 to step 606, and at step 606, method 600 registers a new profile of a new user in the application.
[0077] At step 608, the method 600 involves a specific duration during which an insulin patch device 200 may be configured to attach to the user’s body and used for continuous measurement and recording of glucose levels in the user’s body for three days, employing a glucometer sensor 218.
[0078] Continuing further, at step 610, the method 600 transmits the collected data to the user interface 502. At step 612, now the user configured to send the data to the doctor or specific specialist.
[0079] Continuing further, at step 614, the method 600 signifies a collaborative and technologically facilitated approach. The doctor, leveraging patient-specific information and medical profiles, determines an appropriate dosage of medication, likely related to conditions such as diabetes.
[0080] Continuing further, at step 616, the method 600 involves the integration of medical guidance into a user’s mobile application for streamlined healthcare management. The doctor provides specific instructions related to medication dosages and the intervals at which they should be administered. The user then inputs this information into their mobile app, configuring the application settings to align with the prescribed medical regimen.
[0081] At step 618, the method 600 may be configured to signify the functionality of a user interface designed for diabetes management. The application empowers users by allowing customizing and setting specific parameters related to their insulin intake and blood glucose monitoring. The feature enables the users to align their glucose monitoring with specific times of the day or their individual routines.
[0082] Continuing further, if the determination is no then the step 604 proceeds from step 604 to step 620, involves accessing a user’s personalized account within the user interface.
[0083] Again, at step 622, the method 600 involves the user interface may be configured to send signal to the insulin patch device 200 to measure glucose as per profile of the user using the glucometer sensor 218, and to the insulin delivery device 100.
[0084] Continuing further, at step 624, the method 600 involves the insulin patch device 200 measure the glucose at preconfigured measurement frequency and send that data to the application of that specific user. At step 626, the insulin patch device 200 send the data to the application of the user interface 502, and to the insulin delivery device 100 in real-time.
[0085] Continuing further, at step 628, the method 600 calculates the dosage of insulin to realize in body of the user by using processor 130. The processor 130 is responsible for determining or recognizing the specific amount of insulin that needs to be administered to the user’s body. The information used by the processor 130 to make this determination is preconfigured data, implying that there are preset or predetermined settings or parameters that guide the processor 130 in calculating the appropriate insulin dose. The preconfigured data likely includes factors such as the user’s medical history, prescribed dosage, or other relevant information to ensure accurate insulin delivery.
[0086] At step 630, indicates that there is a computational component i.e the processor 130 within the delivery device 100, and its specific task is to perform a calculation related to a variable referred to as whole number i, where i is the required dosage of insulin in ml divided by the cylinder’s 118 storage volume in ml.
[0087] Continuing further, at step 632, the method 600 involves the quantity of injections or shots to be administered are denoted by the variable i. In this context, i represent a numerical value that determines the count of injections.
[0088] Continuing further, at step 634, the method 600 checks whether i greater than 0 and i is a whole number. If the determination is yes, then the step 634 proceeds from step 634 to step 636, and at step 636, the motors 104 rotate to suck insulin from the reservoir 128 and fill one shot. Furthermore, at step 638, the method 600 involves the motors 104 rotate in opposite direction i.e the first BLDC motor 104-1 rotate in anticlockwise direction and simultaneously the second BLDC motor 104-2 rotate in clockwise direction to inject one shot i=i-1 and the step 634 to the step 638 repeat till i>0.
[0089] If the determination is no, means as soon as i=0, then the step 634 proceeds from the step 634 to step 640, and at step 640, the method 600 suggests a situation in which the motors 104, likely part of a mechanical or electronic device, in this condition, the motors 104 currently at rest or not in motion, and at this time being or within the current circumstances, there is no requirement for additional doses of insulin.
[0090] Moreover, in interpreting the specification, all terms should be interpreted in the broadest possible manner consistent with the context. In particular, the terms “comprises” and “comprising” should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the referenced elements, components, or steps may be present, or utilized, or combined with other elements, components, or steps that are not expressly referenced. Where the specification claims refer to at least one of something selected from the group consisting of A, B, C….and N, the text should be interpreted as requiring only one element from the group, not A plus N, or B plus N, etc.
[0091] While the foregoing describes various embodiments of the invention, other and further embodiments of the invention may be devised without departing from the basic scope thereof. The scope of the invention is determined by the claims that follow. The invention is not limited to the described embodiments, versions or examples, which are comprised to enable a person having ordinary skill in the art to make and use the invention when combined with information and knowledge available to the person having ordinary skill in the art.

ADVANTAGES OF THE PRESENT DISCLOSURE
[0092] The present disclosure a device enables accurate and personalized insulin delivery by incorporating real-time glucose monitoring. This ensures that insulin doses are tailored to the individual’s specific needs, optimizing diabetes management.
[0093] The present disclosure provides the continuous monitoring of glucose levels provides a comprehensive view of the user’s health status.
[0094] The present disclosure provides the accompanying mobile app provides a user-friendly interface for patients and doctors to input insulin dosing information, monitor glucose levels, and receive alerts.
[0095] The present disclosure provides a system allows for automated adjustments to insulin dosages based on real-time glucose data.
[0096] The present disclosure provides a secure locking mechanism, ensuring the protection of sensitive medical data and preventing unauthorized access.
, Claims:1. An insulin delivery device (100) designed to deliver insulin to body of a user with diabetes, comprising:
an outer covering box (102) comprises:
a first brushless DC (BLDC) motor (104-1), and a second brushless DC (BLDC) motor (104-2) mount on a central link (106) and placed inside the outer covering box (102),
wherein the first BLDC motor (104-1), and the second BLDC motor (104-2) facilitates insulin delivery in the body of the user, wherein the first BLDC motor (104-1) comprises a first motor shaft (108-1), and attached to a one side of first major link (110-1) of the first BLDC motor (104-1), wherein the one side of first major link (110-1) further connected to a one side of first minor link (112-1) of the first BLDC motor (104-1);
wherein the second BLDC motor (104-2) comprises a second motor shaft (108-2), and attached to a one side of second major link (110-2) of the second BLDC motor (104-2), wherein the one side of second major link (110-2) further connected to one side of a second minor link (112-2) of the second BLDC motor (104-2); and
wherein the first and second motor shaft (108) of the first and second BLDC motor (104) respectively connected to the first and second major links (110), and first and second minor links (112) to control dosage of the insulin in the body of the user; and
a vertical shaft (114) installed on a piston block (116), wherein the piston block (116) configured to connect with a second side of the first and second minor link (112) of the first and second BLDC motors (104) respectively to synchronize movement of the insulin delivery;
a piston block (116) connected to a cylinder (118) with a plurality of apertures and a piston (120), wherein the plurality of apertures correspondingly connected to a first and second pipes (122);
a first and second valves (124) configured to attach to the first and second pipes (122) to facilitate controlled insulin delivery in the body of the user; and
an infrared (IR) sensor (126) attached to the central link (106) to track movement of the piston (120), and first and second BLDC motor (104), and correspondingly provide a real-time feedback of the insulin delivery device (100).

2. The insulin delivery device (100) as claimed in claim 1, comprises a first Bluetooth device (134) embedded with the insulin delivery device (100) to communicate with a user interface (502).

3. The insulin delivery device (100) as claimed in claim 1, wherein the insulin delivery device (100) configured to receive glucose level data from the insulin patch device (200), analyse the received glucose level data, and correspondingly adjust insulin delivery by the insulin delivery device (100) based on the received glucose level data.

4. The insulin delivery device (100) as claimed in claim 1, wherein one or more power supply unit (400) positioned with the first Bluetooth device (134) inside the outer covering box (102) within the insulin delivery device (100).

5. The insulin delivery device (100) as claimed in claim 1, further comprises a control unit to provide personalized recommendations for insulin dosage based on glucose level data from the body of the user.

6. The insulin delivery device (100) as claimed in claim 1, wherein the control unit is further configured to provide notifications to any or a combination of, the user, and a healthcare provider when the insulin levels in the cylinder fall below predetermined thresholds.

7. The insulin delivery device (100) as claimed in claim 1, further comprises a motor driver with processor (130) attached inside the outer covering box (102) with the first and second BLDC motor (104), and configured to drive rotation of the first and second motor shaft (108).

8. The insulin delivery device (100) as claimed in claim 1, comprises a needle (136) attached to the second pipe (122-2) that leads to a reservoir (128), wherein the second pipe (122-2) configured to insert into the reservoir (128).

9. An insulin patch device (200) for measuring sugar level in body of a user and deliver insulin into the body of the user using an insulin delivery device (100), comprising:
a housing (202) of the insulin patch device (200) positioned below an insulin delivery device (100), and configured to attach with a locking mechanism, comprises: a plurality of syringe (210), comprises;
a first syringe (210-1) attached to a first pipe (122-1) of the insulin delivery device (100) to transfer insulin from a cylinder (118) to the first pipe (122-1) of the insulin delivery device (100); wherein the insulin configured to flow into a patch pipe (214) and be injected into the body of the user using the first syringe 210-1;
a second syringe (210-2) attached to a glucometer sensor (218) within the housing (202) to monitor the user’s body blood glucose level;
a second Bluetooth device (220) embedded within the housing (202) facilitates transmission of a blood glucose data of the user to a computing device and to the insulin delivery device.

10. The insulin patch device (200) as claimed in claim 9, further comprises a cap (208) that rests on a cap holder (206) located on a side wall (204) of the insulin patch device (200) when the insulin delivery device (100) is attached.